Source:http://linkedlifedata.com/resource/pubmed/id/21129235
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2011-3-25
|
pubmed:abstractText |
Previous research suggests that n-3 PUFA may play a role in bone health. The present analysis aimed to investigate the impact of n-3 PUFA supplementation on bone resorption in adult men and women. Serum samples from 113 mild-moderately depressed individuals (twenty-six males and eighty-seven females, aged 18-67 years) randomised to receive 1·48 g EPA+DHA/d (n 53) or placebo (n 60) for 12 weeks as part of a large recent randomised controlled trial were assayed for n-3 PUFA status and a bone resorption marker, C-terminal cross-linking telopeptide of type 1 collagen (?-CTX). Regression analyses revealed that n-3 PUFA status following supplementation was associated with randomisation (placebo/n-3 PUFA) (B = 3·25, 95 % CI 2·60, 3·91, P < 0·01). However, ?-CTX status following supplementation was not associated with randomisation (B = - 0·01, 95 % CI - 0·03, 0·04). Change in ?-CTX status was also not associated with change in n-3 PUFA status (B = - 0·002, 95 % CI - 0·01, 0·01). These findings provide no evidence for an association between n-3 PUFA supplementation (1·48 g EPA+DHA/d) for 12 weeks and bone resorption in humans assessed by ?-CTX, and suggest that n-3 PUFA supplementation may be unlikely to be of benefit in preventing bone loss.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen Type I,
http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Omega-3,
http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Omega-6,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/collagen type I trimeric...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1475-2662
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
105
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1145-9
|
pubmed:meshHeading |
pubmed-meshheading:21129235-Adolescent,
pubmed-meshheading:21129235-Adult,
pubmed-meshheading:21129235-Aged,
pubmed-meshheading:21129235-Biological Markers,
pubmed-meshheading:21129235-Bone Resorption,
pubmed-meshheading:21129235-Collagen Type I,
pubmed-meshheading:21129235-Dietary Supplements,
pubmed-meshheading:21129235-Double-Blind Method,
pubmed-meshheading:21129235-Fatty Acids, Omega-3,
pubmed-meshheading:21129235-Fatty Acids, Omega-6,
pubmed-meshheading:21129235-Female,
pubmed-meshheading:21129235-Humans,
pubmed-meshheading:21129235-Male,
pubmed-meshheading:21129235-Middle Aged,
pubmed-meshheading:21129235-Peptides,
pubmed-meshheading:21129235-Time Factors,
pubmed-meshheading:21129235-Young Adult
|
pubmed:year |
2011
|
pubmed:articleTitle |
Supplementation with a low-moderate dose of n-3 long-chain PUFA has no short-term effect on bone resorption in human adults.
|
pubmed:affiliation |
School of Psychology, Queen's University, Belfast, 18-30 Malone Road, Belfast BT9 5BP, UK. k.appleton@qub.ac.uk
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|